« Return to News | Technology Solutions

K&L Consulting Services selects OpenClinica Enterprise clinical trial software

Wednesday, February 13, 2013 09:34 AM

K&L Consulting Services, a CRO based in Fort Washington, Penn., has selected the OpenClinica Enterprise Edition for Electronic Data Capture (ED”) and clinical data management for phase I-IV clinical trials. K&L is increasing the breadth of its capabilities in the U.S. as well as in Asia and the Pacific region, especially in China.

“We welcome this opportunity to work closely with K&L to help them grow their global practice,” said Ben Baumann, COO at OpenClinica, an open source software company based in Waltham, Mass.

OpenClinica’s commercial open source model stands out in the realm of clinical research software. The company’s strategy is to leverage its rapidly growing global community of users and developers (currently nearly 17,000 people) in order to produce high quality software in a more agile and transparent way for use across the spectrum of clinical research.

“OpenClinica Enterprise allows us to deploy studies quickly and cost effectively, and pass this value on to our clients,” said Dr. Henry Wu, vice president of biostatistics and data management, K&L.

The OpenClinica software is available in two editions: The OpenClinica Community Edition is freely available under a common open source license. The OpenClinica Enterprise Edition pairs the open source technology with a regulatory compliance infrastructure and robust support services.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.